Dr. Anna Perrone, DO
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,587 | 54 | 97.9% |
| Debt forgiveness | $33.41 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $323.73 | 12 | $0 (2024) |
| Novo Nordisk Inc | $252.96 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $229.48 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $197.37 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $178.27 | 4 | $0 (2024) |
| Exact Sciences Corporation | $112.38 | 5 | $0 (2024) |
| ABBVIE INC. | $103.99 | 4 | $0 (2024) |
| DEXCOM, INC. | $91.10 | 1 | $0 (2021) |
| Currax Pharmaceuticals LLC | $50.84 | 3 | $0 (2024) |
| Medtronic, Inc. | $23.97 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $549.28 | 20 | AstraZeneca Pharmaceuticals LP ($178.27) |
| 2023 | $530.62 | 17 | Lilly USA, LLC ($160.03) |
| 2022 | $396.91 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($164.26) |
| 2021 | $143.12 | 4 | DEXCOM, INC. ($91.10) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Obesity | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.96 | General |
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.47 | General |
| 06/26/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Obesity | ||||||
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.36 | General |
| 05/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Oncology | ||||||
| 04/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Obesity | ||||||
| 03/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 02/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Diabetes | ||||||
| 02/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Oncology | ||||||
| 11/02/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: VACCINES | ||||||
| 10/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Gastroenterology | ||||||
| 10/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 484 | 550 | $78,914 | $41,647 |
| 2022 | 10 | 365 | 399 | $52,138 | $28,796 |
| 2021 | 2 | 37 | 42 | $6,956 | $3,886 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $28,765 | $18,200 | 63.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 137 | $18,632 | $8,346 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 83 | $16,754 | $8,129 | 48.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 34 | $3,060 | $2,446 | 79.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 13 | 13 | $2,405 | $1,700 | 70.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $1,665 | $1,203 | 72.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 17 | $2,788 | $834.79 | 29.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 54 | 55 | $3,575 | $490.00 | 13.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 27 | $945.00 | $257.04 | 27.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 11 | 13 | $325.00 | $41.00 | 12.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 65 | 65 | $13,000 | $9,064 | 69.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 60 | $11,400 | $6,073 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 85 | $11,530 | $5,808 | 50.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 41 | 41 | $3,690 | $2,810 | 76.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 46 | $2,070 | $1,471 | 71.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,190 | $1,422 | 44.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,895 | $1,246 | 32.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 23 | 23 | $920.00 | $460.72 | 50.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 35 | 35 | $2,275 | $393.21 | 17.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 14 | $168.00 | $48.10 | 28.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 26 | $4,940 | $2,690 | 54.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 16 | $2,016 | $1,195 | 59.3% |
About Dr. Anna Perrone, DO
Dr. Anna Perrone, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Newington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2018. The National Provider Identifier (NPI) number assigned to this provider is 1316442932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Perrone, DO has received a total of $1,620 in payments from pharmaceutical and medical device companies, with $549.28 received in 2024. These payments were reported across 56 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,587).
As a Medicare-enrolled provider, Perrone has provided services to 886 Medicare beneficiaries, totaling 991 services with total Medicare billing of $74,328. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Newington, CT
- Active Since 03/26/2018
- Last Updated 03/08/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1316442932
Products in Payments
- MOUNJARO (Drug) $311.10
- XIFAXAN (Drug) $229.48
- AIRSUPRA (Drug) $141.29
- JARDIANCE (Drug) $124.98
- Cologuard Collection Kit (Device) $112.38
- DEXCOM G6 TRANSMITTER (Device) $91.10
- Rybelsus (Drug) $89.86
- Wegovy (Drug) $86.44
- UBRELVY (Drug) $81.49
- SPIRIVA RESPIMAT (Drug) $52.83
- CONTRAVE (Drug) $50.84
- BREZTRI (Drug) $36.98
- Ozempic (Drug) $24.87
- VenaSeal (Device) $23.97
- LINZESS (Drug) $22.50
- SHINGRIX (Biological) $22.43
- None (Device) $15.42
- TRULICITY (Drug) $12.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Newington
Dr. Edward Cos, Dmd, DMD
Student in an Organized Health Care Education/Training Program — Payments: $2,891
Alexandra Hac
Student in an Organized Health Care Education/Training Program — Payments: $831.99
Kyler Smith, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $33.74
Mrs. Kathryn Rabinoff, Lcsw, LCSW
Student in an Organized Health Care Education/Training Program
Ms. Lindsey Jason
Student in an Organized Health Care Education/Training Program
Rebecca Spear, D.o, D.O
Student in an Organized Health Care Education/Training Program